Two new publications from the independent thermac trial featuring icecure's prosense® in breast cancer finds 95% of patients satisfied with thermal ablation; prosense® cryoablation achieves highest complete ablation rate

Article published in european journal of surgical oncology focused on cosmetic outcomes and patient satisfaction reports 95% of patients were very satisfied or satisfied with thermal ablation article published in radiology demonstrated that cryoablation with prosense® achieved the highest complete ablation rate compared to alternatives with no adverse events caesarea, israel , sept. 8, 2025 /prnewswire/ -- icecure medical ltd.
ICCM Ratings Summary
ICCM Quant Ranking